Who? Michelle Papka, Ph.D., Director, Cognitive and Research Center of New Jersey
What? To tell, or not to tell? That’s not the question.
Current thinking regarding Alzheimer’s disease diagnosis and intervention
When? 12:00-1:00 on Wednesday, February 20
Where? Hall of Sciences, Room 326
More than 5 million people in the United States have Alzheimer’s disease and this number is projected to increase to 13 million by 2050. Despite the incidence and prevalence, less than 50% of patients are told of their Alzheimer’s diagnosis, and there is no cure. Dr. Michelle Papka is a clinician and researcher who will talk about current clinical and neuropathological criteria for diagnosing Alzheimer’s disease, the impact of this diagnosis on our society, and the theoretical underpinnings for empirical studies aimed at providing new, disease-modifying treatments.